Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact

Center for Computational Systems Medicine
leaf

Gene summary

leaf

Malignant transformation analysis

leaf

Malignant transformation related pathway analysis

leaf

Cell-cell communication analysis

leaf

Single-cell gene regulatory network inference analysis

leaf

Somatic mutation of malignant transformation related genes

leaf

Related drugs of malignant transformation related genes

Gene: BMP4

Gene summary for BMP4

check button Gene summary.

Gene informationSpeciesHuman
Gene symbol

BMP4

Gene ID

652

Gene namebone morphogenetic protein 4
Gene AliasBMP2B
Cytomap14q22.2
Gene Typeprotein-coding
GO ID

GO:0000003

UniProtAcc

P12644


Top

Malignant transformation analysis

check button Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells
check button Malignant transformation involving gene list.
Entrez IDSymbolReplicatesSpeciesOrganTissueAdj P-valueLog2FCMalignancy
652BMP4HTA11_3410_2000001011HumanColorectumAD1.92e-092.49e-010.0155
652BMP4HTA11_2487_2000001011HumanColorectumSER1.14e-021.51e-01-0.1808
652BMP4HTA11_1938_2000001011HumanColorectumAD4.00e-123.59e-01-0.0811
652BMP4HTA11_78_2000001011HumanColorectumAD2.35e-062.68e-01-0.1088
652BMP4HTA11_3361_2000001011HumanColorectumAD5.46e-031.78e-01-0.1207
652BMP4HTA11_696_2000001011HumanColorectumAD9.56e-072.03e-01-0.1464
652BMP4HTA11_1391_2000001011HumanColorectumAD7.00e-134.29e-01-0.059
652BMP4HTA11_866_3004761011HumanColorectumAD1.47e-278.76e-010.096
652BMP4HTA11_4255_2000001011HumanColorectumSER2.17e-095.36e-010.0446
652BMP4HTA11_8622_2000001021HumanColorectumSER1.49e-064.55e-010.0528
652BMP4HTA11_10711_2000001011HumanColorectumAD1.91e-074.51e-010.0338
652BMP4HTA11_6818_2000001021HumanColorectumAD4.64e-165.83e-010.0588
652BMP4HTA11_99999970781_79442HumanColorectumMSS4.78e-481.06e+000.294
652BMP4HTA11_99999965062_69753HumanColorectumMSI-H1.40e-055.83e-010.3487
652BMP4HTA11_99999965104_69814HumanColorectumMSS3.26e-042.22e-010.281
652BMP4HTA11_99999971662_82457HumanColorectumMSS3.40e-531.37e+000.3859
652BMP4HTA11_99999973899_84307HumanColorectumMSS1.05e-125.16e-010.2585
652BMP4HTA11_99999974143_84620HumanColorectumMSS1.92e-357.10e-010.3005
652BMP4A001-C-104HumanColorectumFAP1.92e-041.90e-010.0184
652BMP4A001-C-007HumanColorectumCRC5.46e-032.28e-010.1899
Page: 1 2 3 

check button Transcriptomic changes along malignancy continuum.
TissueExpression DynamicsAbbreviation
Colorectum (GSE201348)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.FAP: Familial adenomatous polyposis
CRC: Colorectal cancer
Colorectum (HTA11)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AD: Adenomas
SER: Sessile serrated lesions
MSI-H: Microsatellite-high colorectal cancer
MSS: Microsatellite stable colorectal cancer
EsophagusThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ESCC: Esophageal squamous cell carcinoma
HGIN: High-grade intraepithelial neoplasias
LGIN: Low-grade intraepithelial neoplasias
LiverThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.HCC: Hepatocellular carcinoma
NAFLD: Non-alcoholic fatty liver disease
Oral CavityThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.EOLP: Erosive Oral lichen planus
LP: leukoplakia
NEOLP: Non-erosive oral lichen planus
OSCC: Oral squamous cell carcinoma
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

check buttonFind out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer
check button Figure of enriched GO biological processes.
TissueDisease StageEnriched GO biological Processes
ColorectumADGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumSERGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSSGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSI-HGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumFAPGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
Page: 1 2 3 4 5 6 7 8 9 

check button Enriched GO biological processes.
GO IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustCount
GO:0072594ColorectumADestablishment of protein localization to organelle148/3918422/187237.95e-121.04e-09148
GO:0002064ColorectumADepithelial cell development89/3918220/187232.98e-113.52e-0989
GO:0048732ColorectumADgland development149/3918436/187236.07e-116.33e-09149
GO:0051098ColorectumADregulation of binding126/3918363/187236.01e-104.88e-08126
GO:2001233ColorectumADregulation of apoptotic signaling pathway119/3918356/187232.14e-081.21e-06119
GO:0006913ColorectumADnucleocytoplasmic transport102/3918301/187231.00e-074.85e-06102
GO:0051169ColorectumADnuclear transport102/3918301/187231.00e-074.85e-06102
GO:0010639ColorectumADnegative regulation of organelle organization114/3918348/187231.41e-076.49e-06114
GO:0051099ColorectumADpositive regulation of binding66/3918173/187231.47e-076.64e-0666
GO:1900180ColorectumADregulation of protein localization to nucleus55/3918136/187231.70e-077.34e-0655
GO:0032386ColorectumADregulation of intracellular transport109/3918337/187235.33e-071.95e-05109
GO:0033157ColorectumADregulation of intracellular protein transport80/3918229/187235.81e-072.09e-0580
GO:0071383ColorectumADcellular response to steroid hormone stimulus73/3918204/187236.31e-072.24e-0573
GO:0034101ColorectumADerythrocyte homeostasis51/3918129/187231.07e-063.59e-0551
GO:0030099ColorectumADmyeloid cell differentiation119/3918381/187231.24e-064.01e-05119
GO:0030879ColorectumADmammary gland development53/3918137/187231.46e-064.58e-0553
GO:0034504ColorectumADprotein localization to nucleus94/3918290/187232.83e-068.09e-0594
GO:0043393ColorectumADregulation of protein binding68/3918196/187235.17e-061.34e-0468
GO:0002262ColorectumADmyeloid cell homeostasis57/3918157/187236.17e-061.56e-0457
GO:0043401ColorectumADsteroid hormone mediated signaling pathway51/3918136/187236.52e-061.63e-0451
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 

check button Enriched KEGG pathways.
Pathway IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustqvalueCount
hsa04919ColorectumADThyroid hormone signaling pathway51/2092121/84651.71e-051.73e-041.10e-0451
hsa05418ColorectumADFluid shear stress and atherosclerosis54/2092139/84651.41e-041.16e-037.37e-0454
hsa049191ColorectumADThyroid hormone signaling pathway51/2092121/84651.71e-051.73e-041.10e-0451
hsa054181ColorectumADFluid shear stress and atherosclerosis54/2092139/84651.41e-041.16e-037.37e-0454
hsa049192ColorectumSERThyroid hormone signaling pathway40/1580121/84651.02e-041.06e-037.67e-0440
hsa054182ColorectumSERFluid shear stress and atherosclerosis40/1580139/84652.28e-031.75e-021.27e-0240
hsa049193ColorectumSERThyroid hormone signaling pathway40/1580121/84651.02e-041.06e-037.67e-0440
hsa054183ColorectumSERFluid shear stress and atherosclerosis40/1580139/84652.28e-031.75e-021.27e-0240
hsa049194ColorectumMSSThyroid hormone signaling pathway46/1875121/84655.04e-054.97e-043.05e-0446
hsa054184ColorectumMSSFluid shear stress and atherosclerosis51/1875139/84656.06e-055.80e-043.55e-0451
hsa04390ColorectumMSSHippo signaling pathway48/1875157/84658.32e-033.10e-021.90e-0248
hsa049195ColorectumMSSThyroid hormone signaling pathway46/1875121/84655.04e-054.97e-043.05e-0446
hsa054185ColorectumMSSFluid shear stress and atherosclerosis51/1875139/84656.06e-055.80e-043.55e-0451
hsa043901ColorectumMSSHippo signaling pathway48/1875157/84658.32e-033.10e-021.90e-0248
hsa054186ColorectumMSI-HFluid shear stress and atherosclerosis25/797139/84651.11e-031.20e-021.01e-0225
hsa049196ColorectumMSI-HThyroid hormone signaling pathway21/797121/84654.18e-034.10e-023.44e-0221
hsa054187ColorectumMSI-HFluid shear stress and atherosclerosis25/797139/84651.11e-031.20e-021.01e-0225
hsa049197ColorectumMSI-HThyroid hormone signaling pathway21/797121/84654.18e-034.10e-023.44e-0221
hsa049198ColorectumFAPThyroid hormone signaling pathway41/1404121/84652.28e-064.28e-052.60e-0541
hsa054188ColorectumFAPFluid shear stress and atherosclerosis45/1404139/84653.05e-064.63e-052.81e-0545
Page: 1 2 3 

Top

Cell-cell communication analysis

check buttonIdentification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states
LigandReceptorLRpairPathwayTissueDisease Stage
BMP4BMPR1A_BMPR2BMP4_BMPR1A_BMPR2BMPCRCAD
BMP4BMPR1A_ACVR2ABMP4_BMPR1A_ACVR2ABMPCRCADJ
BMP4BMPR1A_BMPR2BMP4_BMPR1A_BMPR2BMPCRCADJ
BMP4BMPR1A_ACVR2ABMP4_BMPR1A_ACVR2ABMPCRCMSI-H
BMP4BMPR1A_ACVR2BBMP4_BMPR1A_ACVR2BBMPCRCMSI-H
BMP4BMPR1A_BMPR2BMP4_BMPR1A_BMPR2BMPCRCMSI-H
BMP4BMPR1A_BMPR2BMP4_BMPR1A_BMPR2BMPCRCSER
BMP4BMPR1A_ACVR2BBMP4_BMPR1A_ACVR2BBMPEsophagusESCC
BMP4BMPR1A_BMPR2BMP4_BMPR1A_BMPR2BMPHNSCCPrecancer
BMP4BMPR1A_ACVR2ABMP4_BMPR1A_ACVR2ABMPLiverPrecancer
BMP4BMPR1A_BMPR2BMP4_BMPR1A_BMPR2BMPLiverPrecancer
BMP4BMPR1B_ACVR2ABMP4_BMPR1B_ACVR2ABMPLiverPrecancer
BMP4BMPR1B_BMPR2BMP4_BMPR1B_BMPR2BMPLiverPrecancer
BMP4BMPR1A_BMPR2BMP4_BMPR1A_BMPR2BMPLungAAH
BMP4BMPR1B_BMPR2BMP4_BMPR1B_BMPR2BMPLungAAH
BMP4BMPR1A_ACVR2ABMP4_BMPR1A_ACVR2ABMPTHCAADJ
BMP4BMPR1A_BMPR2BMP4_BMPR1A_BMPR2BMPTHCAADJ
Page: 1 

Top

Single-cell gene regulatory network inference analysis

check buttonFind out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states
TFCell TypeTissueDisease StageTarget GeneRSSRegulon Activity
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
Page: 1 

Top

Somatic mutation of malignant transformation related genes

check buttonAnnotation of somatic variants for genes involved in malignant transformation
Hugo SymbolVariant ClassVariant ClassificationdbSNP RSHGVScHGVSpHGVSp ShortSWISSPROTBIOTYPESIFTPolyPhenTumor Sample BarcodeTissueHistologySexAgeStageTherapy TypesDrugsOutcome
BMP4SNVMissense_Mutationc.404A>Tp.Asn135Ilep.N135IP12644protein_codingtolerated(0.12)benign(0.1)TCGA-AN-A0AR-01Breastbreast invasive carcinomaFemale<65I/IIUnknownUnknownSD
BMP4SNVMissense_Mutationrs747238009c.340N>Tp.Ala114Serp.A114SP12644protein_codingdeleterious(0.04)probably_damaging(0.999)TCGA-E9-A295-01Breastbreast invasive carcinomaFemale>=65I/IIHormone TherapytamoxiphenSD
BMP4deletionFrame_Shift_Delnovelc.179delNp.Thr60AsnfsTer58p.T60Nfs*58P12644protein_codingTCGA-D8-A27V-01Breastbreast invasive carcinomaFemale<65I/IIHormone TherapytamoxiphenSD
BMP4SNVMissense_Mutationrs750868626c.1223N>Ap.Arg408Hisp.R408HP12644protein_codingdeleterious(0)probably_damaging(0.999)TCGA-2W-A8YY-01Cervixcervical & endocervical cancerFemale<65I/IIChemotherapycisplatinCR
BMP4SNVMissense_Mutationrs773416502c.484N>Tp.Arg162Trpp.R162WP12644protein_codingdeleterious(0)probably_damaging(1)TCGA-2W-A8YY-01Cervixcervical & endocervical cancerFemale<65I/IIChemotherapycisplatinCR
BMP4SNVMissense_Mutationnovelc.646N>Cp.Asp216Hisp.D216HP12644protein_codingdeleterious(0)probably_damaging(0.946)TCGA-C5-A2LZ-01Cervixcervical & endocervical cancerFemale>=65III/IVUnknownUnknownPD
BMP4SNVMissense_Mutationc.464N>Gp.Ser155Cysp.S155CP12644protein_codingdeleterious(0.01)probably_damaging(0.976)TCGA-IR-A3LL-01Cervixcervical & endocervical cancerFemale<65I/IIChemotherapycisplatinCR
BMP4SNVMissense_Mutationc.313N>Cp.Glu105Glnp.E105QP12644protein_codingtolerated(0.7)benign(0.015)TCGA-UC-A7PF-01Cervixcervical & endocervical cancerFemale<65I/IIUnknownUnknownSD
BMP4SNVMissense_Mutationnovelc.239N>Tp.Pro80Leup.P80LP12644protein_codingdeleterious(0)probably_damaging(0.995)TCGA-VS-A959-01Cervixcervical & endocervical cancerFemale>=65I/IIUnknownUnknownSD
BMP4SNVMissense_Mutationnovelc.1154A>Gp.Tyr385Cysp.Y385CP12644protein_codingdeleterious(0)probably_damaging(1)TCGA-AA-3811-01Colorectumcolon adenocarcinomaFemale>=65III/IVUnknownUnknownPD
Page: 1 2 3 4 5 6 7 8 

Top

Related drugs of malignant transformation related genes

check buttonIdentification of chemicals and drugs interact with genes involved in malignant transfromation
(DGIdb 4.0)
Entrez IDSymbolCategoryInteraction TypesDrug Claim NameDrug NamePMIDs
Page: 1